Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markert

Showing results (171-180 of 268) with videos related to

Pageof 27
Sort By:
Neuro-Oncology|February 13, 2009
Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastomaNichole L Bryant, Catalina Suarez-Cuervo, G Yancey Gillespie, et al.
Scientific Reports|October 27, 2021
A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomasLawrence S Lamb, Larisa Pereboeva, Samantha Youngblood, et al.
Methods in Cell Biology|May 23, 2017
3D subcellular localization with superresolution array tomography on ultrathin sections of various speciesSebastian M Markert, Vivien Bauer, Thomas S Muenz, et al.
Advances in Radiation Oncology|October 27, 2025
Preoperative Stereotactic Radiosurgery for Brain Metastases: A Phase 1 Dose Escalation Study Demonstrating Reduced Leptomeningeal DiseaseJohn M Hoyle, James M Markert, Kristen O Riley, et al.
Gene|September 6, 2003
Molecular cloning and characterization of human acid sensing ion channel (ASIC)2 gene promoterJiazeng Xia, Zhen Hong Zhou, James K Bubien, et al.
Journal of Neurovirology|May 17, 2007
Effects of G207, a conditionally replication-competent oncolytic herpes simplex virus, on the developing mammalian brainAndrew E Radbill, Alyssa T Reddy, James M Markert, et al.
Cancer Research|May 8, 1999
Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumorsS J Advani, S M Chung, S Y Yan, et al.
The Journal of Laboratory and Clinical Medicine|April 1, 1997
Microheterogeneity of serum glycoproteins and their liver precursors in patients with carbohydrate-deficient glycoprotein syndrome type I: apparent deficiencies in clusterin and serum amyloid PH Henry, J D Tissot, B Messerli, et al.
Plos One|December 7, 2013
Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1David C Gaston, Carl I Odom, Li Li, et al.
Translational Oncology|December 8, 2017
Chimeric HCMV/HSV-1 and Δγ<sub>1</sub>34.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memoryMohammed G Ghonime, Josh Jackson, Amish Shah, et al.
Pageof 27

Showing results (171-180 of 268) with videos related to

Sort By:
Pageof 27
Neuro-Oncology|February 13, 2009
Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastomaNichole L Bryant, Catalina Suarez-Cuervo, G Yancey Gillespie, et al.
Scientific Reports|October 27, 2021
A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomasLawrence S Lamb, Larisa Pereboeva, Samantha Youngblood, et al.
Methods in Cell Biology|May 23, 2017
3D subcellular localization with superresolution array tomography on ultrathin sections of various speciesSebastian M Markert, Vivien Bauer, Thomas S Muenz, et al.
Advances in Radiation Oncology|October 27, 2025
Preoperative Stereotactic Radiosurgery for Brain Metastases: A Phase 1 Dose Escalation Study Demonstrating Reduced Leptomeningeal DiseaseJohn M Hoyle, James M Markert, Kristen O Riley, et al.
Gene|September 6, 2003
Molecular cloning and characterization of human acid sensing ion channel (ASIC)2 gene promoterJiazeng Xia, Zhen Hong Zhou, James K Bubien, et al.
Journal of Neurovirology|May 17, 2007
Effects of G207, a conditionally replication-competent oncolytic herpes simplex virus, on the developing mammalian brainAndrew E Radbill, Alyssa T Reddy, James M Markert, et al.
Cancer Research|May 8, 1999
Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumorsS J Advani, S M Chung, S Y Yan, et al.
The Journal of Laboratory and Clinical Medicine|April 1, 1997
Microheterogeneity of serum glycoproteins and their liver precursors in patients with carbohydrate-deficient glycoprotein syndrome type I: apparent deficiencies in clusterin and serum amyloid PH Henry, J D Tissot, B Messerli, et al.
Plos One|December 7, 2013
Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1David C Gaston, Carl I Odom, Li Li, et al.
Translational Oncology|December 8, 2017
Chimeric HCMV/HSV-1 and Δγ<sub>1</sub>34.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memoryMohammed G Ghonime, Josh Jackson, Amish Shah, et al.
Pageof 27